These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24321784)

  • 1. Use of bone scan during initial prostate cancer workup, downstream procedures, and associated Medicare costs.
    Falchook AD; Salloum RG; Hendrix LH; Chen RC
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):243-8. PubMed ID: 24321784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing the pathways and indications for performing isotope bone scans in newly diagnosed intermediate-risk localised prostate cancer - results from a large contemporaneous cohort.
    KandaSwamy GV; Bennett A; Narahari K; Hughes O; Rees J; Kynaston H
    BJU Int; 2017 Nov; 120(5B):E59-E63. PubMed ID: 28317247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guideline-discordant use of imaging during work-up of newly diagnosed prostate cancer.
    Falchook AD; Hendrix LH; Chen RC
    J Oncol Pract; 2015 Mar; 11(2):e239-46. PubMed ID: 25670199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guideline-discordant androgen deprivation therapy in localized prostate cancer: patterns of use in the medicare population and cost implications.
    Kuykendal AR; Hendrix LH; Salloum RG; Godley PA; Chen RC
    Ann Oncol; 2013 May; 24(5):1338-43. PubMed ID: 23277483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.
    Trogdon JG; Falchook AD; Basak R; Carpenter WR; Chen RC
    JAMA Oncol; 2019 Jan; 5(1):60-66. PubMed ID: 30242397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen, Gleason sum and clinical T stage for predicting the need for radionuclide bone scan for prostate cancer patients in Japan.
    Ishizuka O; Tanabe T; Nakayama T; Kawakami M; Kinebuchi Y; Nishizawa O
    Int J Urol; 2005 Aug; 12(8):728-32. PubMed ID: 16174046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort.
    Palvolgyi R; Daskivich TJ; Chamie K; Kwan L; Litwin MS
    Urology; 2011 Jun; 77(6):1330-6. PubMed ID: 21492911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased resource use in men with metastatic prostate cancer does not result in improved survival or quality of care at the end of life.
    Golan R; Bernstein AN; Gu X; Dinerman BF; Sedrakyan A; Hu JC
    Cancer; 2018 May; 124(10):2212-2219. PubMed ID: 29579318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between low Gleason score and prostate specific antigen levels with incidence of bone metastases in prostate cancer patients: when to omit bone scans?
    Sanjaya IP; Mochtar CA; Umbas R
    Asian Pac J Cancer Prev; 2013; 14(9):4973-6. PubMed ID: 24175761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should bone scan be performed in Chinese prostate cancer patients at the time of diagnosis?
    Wang Y; Guo J; Xu L; Zhao N; Xu Z; Wang H; Zhu Y; Jiang S; Yang N; Yang Y; Wang G
    Urol Int; 2013; 91(2):160-4. PubMed ID: 23548369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing the referral criteria for bone scan in newly diagnosed prostate cancer patients.
    McArthur C; McLaughlin G; Meddings RN
    Br J Radiol; 2012 Apr; 85(1012):390-4. PubMed ID: 21304009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan.
    Kosuda S; Yoshimura I; Aizawa T; Koizumi K; Akakura K; Kuyama J; Ichihara K; Yonese J; Koizumi M; Nakashima J; Fujii H
    Cancer; 2002 Feb; 94(4):964-72. PubMed ID: 11920464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
    Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
    BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective study of predictors of bone metastasis in prostate cancer cases.
    Ho CC; Seong PK; Zainuddin ZM; Abdul Manaf MR; Parameswaran M; Razack AH
    Asian Pac J Cancer Prev; 2013; 14(5):3289-92. PubMed ID: 23803117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer.
    Huncharek M; Muscat J
    Cancer Invest; 1995; 13(1):31-5. PubMed ID: 7530590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which patients with newly diagnosed prostate cancer need a computed tomography scan of the abdomen and pelvis? An analysis based on 588 patients.
    Lee N; Newhouse JH; Olsson CA; Benson MC; Petrylak DP; Schiff PB; Bagiella E; Malyszko B; Ennis RD
    Urology; 1999 Sep; 54(3):490-4. PubMed ID: 10475360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is bone scintigraphy necessary in initial staging of prostate cancer patients?
    Jaukovic L; Adjinovic B; Cerovic S; Joksimovic M; Soldatovic Z
    Hell J Nucl Med; 2011; 14(2):126-30. PubMed ID: 21761013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL?
    Lee SH; Chung MS; Park KK; Yom CD; Lee DH; Chung BH
    World J Urol; 2012 Apr; 30(2):265-9. PubMed ID: 21779835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying downstream impact of inappropriate staging imaging in a cohort of veterans with low- and intermediate-risk incident prostate cancer.
    Drangsholt S; Walter D; Ciprut S; Lepor A; Sedlander E; Curnyn C; Loeb S; Malloy P; Winn AN; Makarov DV
    Urol Oncol; 2019 Feb; 37(2):145-149. PubMed ID: 30578160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.